Neuro-Oncological Ventral Antigen 1 (NOVA1) Peptid
NOVA1
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle NOVA1 Produkte
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- TNGYFGAASP LAASAILGTE KSTDGSKDVV EIAVPENLVG AILGKGGKTL
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of NOVA1 antibody, catalog no. 70R-5002
-
Neuro-Oncological Ventral Antigen 1 (NOVA1) peptide
NOVA1 Reaktivität: Human Wirt: Synthetic BP, Imm
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Synonyme
- Nova-1 Peptide, NOVA1 Peptide, si:ch211-222c22.9 Peptide, 9430099M15Rik Peptide, G630039L02 Peptide, NOVA alternative splicing regulator 1 Peptide, neuro-oncological ventral antigen 1 L homeolog Peptide, neuro-oncological ventral antigen 1 Peptide, RNA-binding protein Nova-1 Peptide, lipid A export ATP-binding/permease protein Peptide, NOVA1 Peptide, Nova1 Peptide, nova1.L Peptide, nova1 Peptide, LOC790874 Peptide, novA1 Peptide
-
Sie sind hier:
